Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;22(9):1056-1063.
doi: 10.1038/s41556-020-0559-z. Epub 2020 Aug 17.

UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination

Jiang Liu #  1 , Di Guan #  1 , Maogong Dong  1 , Jingjing Yang  1 , Haibin Wei  2 , Qian Liang  1 , Lizhi Song  1 , Lu Xu  1 , Junjie Bai  1 , Cui Liu  1 , Jian Mao  1 , Qian Zhang  1 , Junzhi Zhou  1 , Xiaoying Wu  1 , Miao Wang  1 , Yu-Sheng Cong  3
Affiliations

UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination

Jiang Liu et al. Nat Cell Biol. 2020 Sep.

Abstract

p53 is the most intensively studied tumour suppressor1. The regulation of p53 homeostasis is essential for its tumour-suppressive function2,3. Although p53 is regulated by an array of post-translational modifications, both during normal homeostasis and in stress-induced responses2-4, how p53 maintains its homeostasis remains unclear. UFMylation is a recently identified ubiquitin-like modification with essential biological functions5-7. Deficiency in this modification leads to embryonic lethality in mice and disease in humans8-12. Here, we report that p53 can be covalently modified by UFM1 and that this modification stabilizes p53 by antagonizing its ubiquitination and proteasome degradation. Mechanistically, UFL1, the UFM1 ligase6, competes with MDM2 to bind to p53 for its stabilization. Depletion of UFL1 or DDRGK1, the critical regulator of UFMylation6,13, decreases p53 stability and in turn promotes cell growth and tumour formation in vivo. Clinically, UFL1 and DDRGK1 expression are downregulated and positively correlated with levels of p53 in a high percentage of renal cell carcinomas. Our results identify UFMylation as a crucial post-translational modification for maintenance of p53 stability and tumour-suppressive function, and point to UFMylation as a promising therapeutic target in cancer.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Dolgin, E. The most popular genes in the human genome. Nature 551, 427–431 (2017). - DOI
    1. Kastenhuber, E. R. & Lowe, S. W. Putting p53 in context. Cell 170, 1062–1078 (2017). - DOI
    1. Vousden, K. H. & Prives, C. Blinded by the light: the growing complexity of p53. Cell 137, 413–431 (2009). - DOI
    1. Kruse, J. P. & Gu, W. Modes of p53 regulation. Cell 137, 609–622 (2009). - DOI
    1. Komatsu, M. et al. A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier. EMBO J. 23, 1977–1986 (2004). - DOI

Publication types

LinkOut - more resources